等待開盤 07-19 09:30:00 美东时间
-2.420
-0.40%
今日重点评级关注:花旗:维持百度"买入"评级,目标价从138美元升至140美元;Maxim Group:维持Caledonia Mining"买入"评级,目标价从21美元升至28美元
07-18 09:25
Oppenheimer analyst Noah Kaye maintains Lennox Intl (NYSE:LII) with a Outperform and raises the price target from $600 to $650.
07-17 20:35
今日重点评级关注:B. Riley证券:维持内克塔治疗"买入"评级,目标价从60美元升至85美元;Oppenheimer:维持Praxis Precision Medicine"跑赢大市"评级,目标价从97美元升至115美元
07-09 09:26
Across the recent three months, 9 analysts have shared their insights on Lennox...
07-09 02:01
Goldman Sachs analyst Joe Ritchie maintains Lennox Intl (NYSE:LII) with a Buy and raises the price target from $619 to $691.
07-09 01:38
Lennox International (NYSE:LII) said in an SEC filing that director John Norris sold $1.93M worth of shares in the climate control solutions provider. Norris sold 3,190 shares at $606 per share, and i...
07-08 02:13
DALLAS, July 7, 2025 /PRNewswire/ -- Lennox (NYSE: LII), a leader in energy-efficient climate control solutions, will report second quarter 2025 financial results before the market opens on ...
07-07 21:03
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners:维持再鼎医药(ZLAB)"跑赢大市"评级,目标价从73美元升至75美元</p> <p>• 美银证券:维持BioCryst Pharma(BCRX)"买入"评级,目标价从13美元升至15美元
07-02 09:54
Wells Fargo analyst Joseph O'Dea maintains Lennox Intl (NYSE:LII) with a Underweight and raises the price target from $500 to $550.
07-01 22:19
In the current session, the stock is trading at $571.18, after a 0.65% spike. O...
07-01 03:00